Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG Topic: Diabetes

Diabetes is a disease characterized by the body's inability to sufficiently produce insulin to properly metabolize carbohydrates. The three main forms the condition are Type 1, Type 2, and gestational diabetes. Type 1 diabetes is a chronic disease characterized by destruction of beta-cells of the pancreas. Type 2 diabetes develops when the body becomes resistant to the effects of insulin. Gestational diabetes is usually a temporary disorder occurring during pregnancy when insulin resistance develops due to hormonal changes and weight gain.

Request a consultation







Leading Experts: Diabetes

What is a GLG Leader?
Michael Dempsey, Medical Director, Johns Hopkins Diabetes Center at Suburban HospitalMichael Dempsey
Medical Director
Johns Hopkins Diabetes Center at Suburban Hospital

Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...

Joshua Cohen, MD
Associate Professor and Director
THE GEORGE WASHINGTON UNIVERSITY

Joshua Cohen, MD, is an Associate Professor of Medicine and Director of the Diabetes Center in the Division of Endocrinology and Metabolism at The George Washington University Medical Center. He was a Medical Staff Fellow at the National Institutes of Arthritis, Diabetes, Digestive and Kidney Diseases,...

Dan Streja, MD
Clinical Professor of Medicine
University of California, Los Angeles

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is the Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja...

Satish Garg, MD
Chief of Young Adult Diabetes Clinic
BARBARA DAVIS CENTER FOR CHILDHOOD DIABETES

Satish Garg, MD, is a Professor of Medicine and Pediatrics at University of Colorado School of Medicine. He is also Chief of Young Adult Diabetes Clinic and Director of Barbara Davis Center for Childhood Diabetes at University of Colorado Health Sciences Center. Dr. Garg has research interest in microvascular...

RoseMarie Pasmantier, MD
Director, Diabetes Outpatient Department
SUNY Downstate Medical Center - CC

RoseMarie Pasmantier, MD, is the Director of Diabetes Outpatient Department at State University of New York at Stony Brook. Dr. Pasmantier has experience in the treatment of metabolic disorders. Her research interests include new treatments for type 2 diabetes and dyslipidemia. Dr. Pasmantier has been...

View All GLG Leaders in Healthcare

GLG NewsSM Analysis: Diabetes(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Rounding Out Lilly's Diabetes Armamentarium | 03-19-2008
Author: GLG Expert Contributor

The most obvious (potential) benefit to Lilly of its collaboration agreement with Transition is that it will be adding one more potential class of diabetic therapies to its product line.  Lilly already has Humulin (longer-acting insulin), Humalog (a rapid acting insulin), Actos and exenatide (a...

diabetic neuropathy commonest presentation in long standing diabetic | 03-24-2008
Author: GLG Expert Contributor

India will become capital of diabetes in few years This molecule will help diabetic patients with neuropathic pain. aT PRESENT PREGABALIN GABAPENTIN and Methylcobalamin IS USED TO TREAT NEUROPATHY with variable results.

Clinical trial for AEG33773 for the treatment of painful diabetic neuropathy begins with human population group | 03-24-2008
Author: GLG Expert Contributor

Diabetes is one of most common disease suffered by millions around the world, yet treatment options are limited, and mainly confined with few oral medicines, insulin regulator bio-chemical treatment and other alternative medicines. The prospect of AEG33773, as an orally bioavailable small molecule...

Taranabant directions: To gain or to Failure | 04-07-2008
Author: GLG Expert Contributor

The market is hungry for a weight loss drug with diabetes benefit. Currently, the FAD has phobia of the SEs with new drugs in this category Failure of Rimonabant was due to wrong direction of Sanofi Aventis in their approach to the FDA Taranabant may have better luck, especially if Merck take...

Hefty price but promising potential | 04-28-2008
Author: GLG Expert Contributor

Situins are enzymes that regulate predetermined cell death, activity in muscle and fat cells as well as energy expenditure. There are several classes of these enzymes (SIRT 1 through 7). The technology is promising in that it promises to regulate some of the causes of diabetes and obesity rather than...

View All GLG News in Healthcare

GLG InstituteSM Seminars: Diabetes(?)

 
Recent Seminars
View All View all GLG InstituteSM Seminars in in Healthcare

Quick Facts about GLG

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics